The Prevalence Of Osteoarthritis In Young People, Is Arthrosamid The Answer?
![Osteoarthritis](https://amsk.co.uk/wp-content/uploads/2023/01/amsk-1024x597.jpg)
Osteoarthritis is the most common form of arthritis, affecting millions of people worldwide. It is a degenerative disease of the joints that can cause pain, stiffness, and swelling and can lead to people having knee replacements earlier than required. In the past, osteoarthritis was considered a disease of the elderly, but it is now known […]
What is Arthrosamid?
![Arthrosamid](https://amsk.co.uk/wp-content/uploads/2023/01/AMSK-Blog-1024x597.jpg)
Athrosamid is a new type of treatment that can offer patients an effective, and non-invasive alternative to current treatments. It is a non-biodegradable hydrogel that is injected into the knee and cushions the joint to relieve the pain. What can Arthrosamid treat? This treatment is best used on patients with knee osteoarthritis. Osteoarthritis […]
IRELAND’S ORTHOPAEDICS MARKET IS SET TO EMBRACE ‘INNOVATIVE AND EXCITING’ TREATMENT TO HELP EASE PAIN CAUSED BY KNEE OSTEOARTHRITIS
![](https://amsk.co.uk/wp-content/uploads/2022/12/news4-1024x597.jpg)
Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection approved in Europe for the treatment of knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing osteoarthritis, which affects around one in four adults in Ireland aged over 601 (over 400,000 people)2 and […]
A NEW CLASS OF “INJECTABLES” TO ENTER ITALY’S ORTHOPAEDIC MARKET THANKS TO A DYNAMIC PARTNERSHIP WITH MEDICAL MANUFACTURERS CONTURA ORTHOPAEDICS
![](https://amsk.co.uk/wp-content/uploads/2022/12/news3-1024x597.jpg)
Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection, approved in Europe to treat knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing OA, which affects around 8,6 million people in Italy1…current treatments are not long-lasting or involve invasive knee replacement surgery. […]
PATIENTS GAIN ACCESS TO INNOVATIVE NEW PROCEDURE FOR TREATING KNEE OSTEOARTHRITIS AS HCA UK PARTNERS WITH CONTURA ORTHOPAEDICS
![](https://amsk.co.uk/wp-content/uploads/2022/12/news2-1024x597.jpg)
London, September 2022; Contura Orthopaedics Ltd is pleased to announce that a major hospital group has signed up to Arthrosamid, allowing clinicians to offer this novel procedure to its patients in London and across the UK. musculoskeletal disorders in addition to sporting injuries and complaints at its state-of-the-art facility located on Tottenham Court Road in […]
GET TO KNOW YOUR KNEES – AN AUDIENCE WITH PROFESSOR PAUL LEE AT 108 HARLEY STREET MONDAY 21 NOVEMBER
![](https://amsk.co.uk/wp-content/uploads/2022/12/news1-1024x597.jpg)
Around 8.5 million people in the UK (that’s around 1 in 5 people aged over 45 in England1) live with the discomfort of osteoarthritis (OA). Despite this large suffering population, many current treatments and medications have limited impact or unpleasant side-effects, with invasive knee replacement surgery often viewed as the inevitable solution for those affected by OA […]